SG10202103336SA - Novel coelenterazine substrates and methods of use - Google Patents
Novel coelenterazine substrates and methods of useInfo
- Publication number
- SG10202103336SA SG10202103336SA SG10202103336SA SG10202103336SA SG10202103336SA SG 10202103336S A SG10202103336S A SG 10202103336SA SG 10202103336S A SG10202103336S A SG 10202103336SA SG 10202103336S A SG10202103336S A SG 10202103336SA SG 10202103336S A SG10202103336S A SG 10202103336SA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- novel coelenterazine
- coelenterazine substrates
- substrates
- novel
- Prior art date
Links
- YHIPILPTUVMWQT-UHFFFAOYSA-N Oplophorus luciferin Chemical compound C1=CC(O)=CC=C1CC(C(N1C=C(N2)C=3C=CC(O)=CC=3)=O)=NC1=C2CC1=CC=CC=C1 YHIPILPTUVMWQT-UHFFFAOYSA-N 0.000 title 2
- 239000000758 substrate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/66—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving luciferase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
- C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
- C12Y113/12005—Renilla-luciferin 2-monooxygenase (1.13.12.5), i.e. renilla-luciferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
- C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
- C12Y113/12007—Photinus-luciferin 4-monooxygenase (ATP-hydrolysing) (1.13.12.7), i.e. firefly-luciferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
- C12Y113/12—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of one atom of oxygen (internal monooxygenases or internal mixed function oxidases)(1.13.12)
- C12Y113/12013—Oplophorus-luciferin 2-monooxygenase (1.13.12.13)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US40942210P | 2010-11-02 | 2010-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10202103336SA true SG10202103336SA (en) | 2021-04-29 |
Family
ID=44983728
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201607774RA SG10201607774RA (en) | 2010-11-02 | 2011-11-02 | Novel coelenterazine substrates and methods of use |
| SG10202103336SA SG10202103336SA (en) | 2010-11-02 | 2011-11-02 | Novel coelenterazine substrates and methods of use |
| SG10201608550SA SG10201608550SA (en) | 2010-11-02 | 2011-11-02 | Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use |
| SG2013033675A SG190104A1 (en) | 2010-11-02 | 2011-11-02 | Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use |
| SG2013030366A SG189496A1 (en) | 2010-11-02 | 2011-11-02 | Novel coelenterazine substrates and methods of use |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201607774RA SG10201607774RA (en) | 2010-11-02 | 2011-11-02 | Novel coelenterazine substrates and methods of use |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201608550SA SG10201608550SA (en) | 2010-11-02 | 2011-11-02 | Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use |
| SG2013033675A SG190104A1 (en) | 2010-11-02 | 2011-11-02 | Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use |
| SG2013030366A SG189496A1 (en) | 2010-11-02 | 2011-11-02 | Novel coelenterazine substrates and methods of use |
Country Status (15)
| Country | Link |
|---|---|
| US (10) | US8809529B2 (fr) |
| EP (4) | EP3498710A1 (fr) |
| JP (6) | JP5889910B2 (fr) |
| KR (2) | KR101939553B1 (fr) |
| CN (3) | CN103370319B (fr) |
| AU (2) | AU2011323418B2 (fr) |
| BR (2) | BR112013010855A2 (fr) |
| CA (3) | CA2817102C (fr) |
| DK (2) | DK2635595T3 (fr) |
| ES (2) | ES2723773T3 (fr) |
| IL (5) | IL225867B (fr) |
| PL (2) | PL2635595T3 (fr) |
| PT (1) | PT2635595T (fr) |
| SG (5) | SG10201607774RA (fr) |
| WO (2) | WO2012061530A2 (fr) |
Families Citing this family (82)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2308978B8 (fr) | 2003-10-10 | 2015-04-08 | Promega Corporation | Biocapteur à la luciférase |
| US9359635B2 (en) | 2006-04-03 | 2016-06-07 | Promega Corporation | Permuted and nonpermuted luciferase biosensors |
| EP2281046B1 (fr) | 2008-05-19 | 2012-01-25 | Promega Corporation | Biocapteurs de luciférase pour l'ampc |
| JP6038649B2 (ja) | 2009-05-01 | 2016-12-07 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | 増大した光出力を有する合成オプロフォルスルシフェラーゼ |
| WO2011143339A1 (fr) | 2010-05-11 | 2011-11-17 | Promega Corporation | Biocapteurs de protéase mutante dotés de caractéristiques de détection améliorées |
| US9290794B2 (en) * | 2010-05-11 | 2016-03-22 | Promega Corporation | Mutant protease biosensors with enhanced detection characteristics |
| JP5889910B2 (ja) | 2010-11-02 | 2016-03-22 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | 新規セレンテラジン基質及び使用法 |
| PT2635583E (pt) | 2010-11-02 | 2015-09-11 | Promega Corp | Derivados da coelenterazina e métodos de utilização da mesma |
| EP2782916B1 (fr) | 2011-11-21 | 2018-02-28 | Promega Corporation | Analogues de carboxy x rhodamine |
| WO2014093671A1 (fr) | 2012-12-12 | 2014-06-19 | Promega Corporation | Compositions et procédés de capture de cibles cellulaires d'agents bioactifs |
| WO2014093677A1 (fr) * | 2012-12-12 | 2014-06-19 | Promega Corporation | Reconnaissance de liaison d'une cible cellulaire par un agent bioactif à l'aide d'un transfert d'énergie de résonance de bioluminescence intracellulaire |
| US10067149B2 (en) | 2012-12-12 | 2018-09-04 | Promega Corporation | Recognition of cellular target binding by a bioactive agent using intracellular bioluminescence resonance energy transfer |
| JP6511720B2 (ja) | 2013-02-28 | 2019-05-15 | Jnc株式会社 | コドン最適化変異エビルシフェラーゼ遺伝子およびその使用方法 |
| KR20150129721A (ko) | 2013-03-15 | 2015-11-20 | 프로메가 코포레이션 | 구조적 보완에 의한 바이오발광성의 활성화 |
| US10168323B2 (en) | 2013-03-15 | 2019-01-01 | Promega Corporation | Compositions and methods for capture of cellular targets of bioactive agents |
| WO2014151282A1 (fr) | 2013-03-15 | 2014-09-25 | Promega Corporation | Substrats pour la fixation covalente de protéines à des groupes fonctionnels ou des surfaces solides |
| US9340817B2 (en) | 2013-03-27 | 2016-05-17 | Sample6 Technologies, Inc. | Methods of making recombinant phage, compositions and articles of manufacture of same for bacterial detection |
| JP6040846B2 (ja) * | 2013-04-08 | 2016-12-07 | Jnc株式会社 | セレンテラジン類縁体 |
| EP3011062A4 (fr) * | 2013-06-19 | 2017-06-14 | Sample6 Technologies Inc. | Analyse, fondée sur des phages, utilisable en vue de la détection de bactéries |
| US11408899B2 (en) * | 2013-07-12 | 2022-08-09 | The Children's Hospital Of Philadelphia | AAV vector and assay for anti-AAV (adeno-associated virus) neutralizing antibodies |
| US9952208B2 (en) | 2013-07-18 | 2018-04-24 | ECOLE POLYTECHNIQUE FéDéRALE DE LAUSANNE | Means and methods for bioluminescence resonance energy transfer (BRET) analysis in a biological sample |
| JP6484987B2 (ja) | 2013-10-21 | 2019-03-20 | Jnc株式会社 | エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法 |
| WO2015067302A1 (fr) | 2013-11-05 | 2015-05-14 | Ecole Polytechnique Federale De Lausanne (Epfl) | Molécules capteurs et leurs utilisations |
| JP6442825B2 (ja) | 2013-12-26 | 2018-12-26 | Jnc株式会社 | エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法 |
| JP6703484B2 (ja) | 2014-01-29 | 2020-06-03 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | 細胞による取り込み測定のための、標識用試薬としての、キノンでマスクされたプローブ |
| US9927430B2 (en) | 2014-01-29 | 2018-03-27 | Promega Corporation | Pro-substrates for live cell applications |
| JP6256118B2 (ja) * | 2014-03-11 | 2018-01-10 | Jnc株式会社 | エビルシフェラーゼの触媒蛋白質のキメラ遺伝子及びその使用法 |
| JP6265020B2 (ja) | 2014-04-16 | 2018-01-24 | Jnc株式会社 | エビルシフェラーゼの触媒蛋白質の変異遺伝子とその使用法 |
| AU2015263901B2 (en) | 2014-05-23 | 2021-03-11 | Promega Corporation | Compositions and methods for stabilizing luminogenic substrates |
| JP6811173B2 (ja) | 2014-09-11 | 2021-01-13 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | 増強された発光を産生するために赤外発光基質を活用するルシフェラーゼ配列 |
| EP4219736A1 (fr) | 2014-09-12 | 2023-08-02 | Promega Corporation | Marqueurs protéiques internes |
| US11365402B2 (en) * | 2014-09-12 | 2022-06-21 | Promega Corporation | Internal protein tags |
| WO2016098078A2 (fr) * | 2014-12-19 | 2016-06-23 | Novartis Ag | Commutateurs de dimérisation et leurs utilisations |
| EP3254113A4 (fr) | 2015-02-05 | 2018-06-27 | Promega Corporation | Analyses à variation thermique fondées sur la luciférase |
| JP6876002B2 (ja) | 2015-06-05 | 2021-05-26 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | 機能的要素を共有結合により係留させるための細胞透過性、細胞適合性、かつ開裂可能であるリンカー |
| WO2016210294A1 (fr) | 2015-06-25 | 2016-12-29 | Promega Corporation | Composés de thiénopyrrole et leurs utilisations à titre d'inhibiteurs de luciférases dérivées d'oplophorus |
| US20170029798A1 (en) * | 2015-07-27 | 2017-02-02 | Cellivery Therapeutics, Inc. | Development of Improved Cell-Permeable (iCP) Parkin Recombinant Protein as a Protein-Based Anti-Neurodegenerative Agent for the Treatment of Parkinson's Disease-Associated Phenotypes by Utilizing BBB-Penetrating Protein Delivery System MITT, Enabled by Advanced Macromolecule Transduction Domain (aMTD) |
| EP3416968B1 (fr) | 2016-02-15 | 2022-07-27 | Promega Corporation | Analogues de coelentérazine |
| JP6441534B2 (ja) | 2016-03-11 | 2018-12-19 | 国立研究開発法人産業技術総合研究所 | 発光酵素タンパク質 |
| WO2017189751A1 (fr) | 2016-04-26 | 2017-11-02 | The University Of Utah Research Foundation | Systèmes rapporteurs de division activés se liant à une cible pour la détection d'analytes, ainsi que composants et procédés associés |
| CN105968114B (zh) * | 2016-05-27 | 2018-11-09 | 山东大学 | 一种腔肠素类似物及其制备方法与应用 |
| US10000500B2 (en) | 2016-07-28 | 2018-06-19 | Promega Corporation | Coelenterazine analogues |
| US10202584B2 (en) * | 2016-09-01 | 2019-02-12 | The Regents Of The University Of California | Red-shifted luciferase-luciferin pairs for enhanced bioluminescence |
| WO2018049241A1 (fr) | 2016-09-09 | 2018-03-15 | Promega Corporation | Substrats de pro-coelentérazine à double protection |
| US10280447B2 (en) | 2016-11-01 | 2019-05-07 | Promega Corporation | Substituted imidazo[1,2-A]pyrazines tethered to energy acceptors |
| US10400264B2 (en) * | 2016-12-01 | 2019-09-03 | Promega Corporation | 5,5-disubstituted luciferins and their use in luciferase-based assays |
| DK3548492T3 (en) * | 2016-12-01 | 2023-08-07 | Promega Corp | Cell impermeable coelenterazine analogues |
| EP3562823B1 (fr) | 2016-12-28 | 2023-02-08 | Promega Corporation | Inhibiteurs de nanoluc fonctionnalisés |
| US11959121B2 (en) | 2017-05-30 | 2024-04-16 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Sensors, methods and kits for detecting NADPH based on resonance energy transfer |
| WO2019010094A1 (fr) | 2017-07-06 | 2019-01-10 | Promega Corporation | Analogues de pro-coelentérazine stables sériques |
| CN108107209B (zh) * | 2017-09-19 | 2020-07-24 | 中国中医科学院医学实验中心 | 一种检测分泌型报告蛋白含量的优化方法及其所用生物材料 |
| EP3788048A1 (fr) * | 2018-05-01 | 2021-03-10 | Promega Corporation | Composés de coelentérazine utilisés en tant que substrats suicide de nanoluc |
| US11442063B2 (en) | 2018-05-30 | 2022-09-13 | Promega Corporation | Broad spectrum kinase binding agents |
| EP3802514B1 (fr) | 2018-06-01 | 2022-08-03 | Promega Corporation | Inhibiteurs de complexes bioluminescents dérivés de la luciférase oplophorus |
| US10962538B2 (en) | 2018-06-14 | 2021-03-30 | The Trustees Of Columbia University In The City Of New York | Assays using arrestin recruitment and unmodified receptors |
| WO2020023871A1 (fr) | 2018-07-27 | 2020-01-30 | Promega Corporation | Conjugués contenant de la quinone |
| EP3841173A1 (fr) * | 2018-08-23 | 2021-06-30 | Promega Corporation | Analogues de coelentérazine |
| EP4015644A1 (fr) | 2018-10-03 | 2022-06-22 | Promega Corporation | Compositions et procédés de stabilisation de coelentérazine et analogues et dérivés associés |
| JP2022509200A (ja) | 2018-11-28 | 2022-01-20 | プロメガ コーポレイション | 反応性ペプチド標識付け |
| EP3891503A2 (fr) | 2018-12-04 | 2021-10-13 | Promega Corporation | Agents de liaison aux rcpg à large spectre |
| WO2020176755A1 (fr) * | 2019-02-27 | 2020-09-03 | University Of Virginia Patent Foundation | Variants de rapporteurs bioluminescents indépendants de l'atp pour améliorer l'imagerie in vivo |
| JP2022526907A (ja) | 2019-03-20 | 2022-05-27 | プロメガ コーポレイション | 光親和性プローブ |
| US11360096B2 (en) | 2019-05-16 | 2022-06-14 | Duke University | Complex BRET technique for measuring biological interactions |
| WO2020263825A1 (fr) | 2019-06-24 | 2020-12-30 | Promega Corporation | Polymères de polyamine modifiés pour l'administration de biomolécules dans des cellules |
| WO2021108765A1 (fr) | 2019-11-27 | 2021-06-03 | Promega Corporation | Peptides et polypeptides de luciférase multipartites |
| EP4073512A1 (fr) | 2019-12-10 | 2022-10-19 | Promega Corporation | Compositions et méthodes de détection de bioluminescence à l'aide de sondes multifonctionnelles |
| EP3882632A1 (fr) | 2020-03-18 | 2021-09-22 | Universite De Bordeaux | Nouvelles sous-unités de fusion de canal conducteur d'ions et leurs procédés d'utilisation |
| CN113527231A (zh) * | 2020-04-15 | 2021-10-22 | 深圳华大生命科学研究院 | 杂环取代腔肠素类化合物的合成方法 |
| EP3904508A1 (fr) | 2020-04-27 | 2021-11-03 | Institut Pasteur | Dosage immunoenzymatique lié à la luciférase |
| US20210363565A1 (en) | 2020-05-22 | 2021-11-25 | Promega Corporation | Enhancement of kinase target engagement |
| JP2023540934A (ja) | 2020-08-28 | 2023-09-27 | プロメガ コーポレイション | Ｒａｓタンパク質のターゲットエンゲージメントアッセイ |
| EP4257978A1 (fr) | 2020-12-25 | 2023-10-11 | Chugai Seiyaku Kabushiki Kaisha | Procédé de criblage d'une molécule candidate susceptible de former un complexe en conjonction avec une pluralité de molécules cibles |
| CN115161296A (zh) * | 2021-04-01 | 2022-10-11 | 深圳华大生命科学研究院 | 一种刺虾荧光素酶Nluc的突变体及其应用 |
| KR20240046876A (ko) * | 2021-08-24 | 2024-04-11 | 앵스띠뛰 파스퇴르 | 발광 기반 항원 분석 |
| US20240060059A1 (en) | 2022-05-04 | 2024-02-22 | Promega Corporation | Circularly permuted dehalogenase variants |
| WO2023215514A2 (fr) | 2022-05-04 | 2023-11-09 | Promega Corporation | Marquage photocatalytique déclenché par bioluminescence |
| US20240132859A1 (en) | 2022-05-04 | 2024-04-25 | Promega Corporation | Modified dehalogenase with extended surface loop regions |
| US20240174992A1 (en) | 2022-05-04 | 2024-05-30 | Promega Corporation | Split modified dehalogenase variants |
| CN115349611B (zh) * | 2022-08-05 | 2023-10-24 | 江南大学 | 一种改善南美白对虾虾糜凝胶品质的方法 |
| CN116068198B (zh) * | 2022-11-30 | 2024-01-09 | 深圳湾实验室 | Ppi原位检测方法及其载体、诊断试剂、试剂盒和应用 |
| JP7482563B1 (ja) | 2023-06-21 | 2024-05-14 | 国立大学法人大阪大学 | シイノトモシビタケ由来の発光関連遺伝子 |
| GB202404021D0 (en) | 2024-03-20 | 2024-05-01 | Ipsen Biopharm Ltd | Cell-based neurotoxin assay |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3477549D1 (en) | 1983-08-17 | 1989-05-11 | Allied Signal Inc | Gas generator and method of generating gas |
| JPH0515398A (ja) | 1991-07-15 | 1993-01-26 | Nippon Oil & Fats Co Ltd | オキシダーゼ酵素の定量方法 |
| US5368484A (en) | 1992-05-22 | 1994-11-29 | Atari Games Corp. | Vehicle simulator with realistic operating feedback |
| US6387675B1 (en) | 1994-01-03 | 2002-05-14 | Promega Corporation | Mutant luciferases |
| EP0689587B1 (fr) | 1994-01-03 | 2008-04-09 | Promega Corporation | Luciferases mutantes |
| GB9501170D0 (en) | 1994-03-23 | 1995-03-08 | Secr Defence | Luciferases |
| JP3648763B2 (ja) | 1994-08-23 | 2005-05-18 | 日本油脂株式会社 | ウミホタルルシフェリン誘導体および糖加水分解酵素の定量方法 |
| GB9417593D0 (en) | 1994-09-01 | 1994-10-19 | Secr Defence | Luciferase labelling method |
| US5670356A (en) | 1994-12-12 | 1997-09-23 | Promega Corporation | Modified luciferase |
| DE69633171T2 (de) | 1995-01-20 | 2005-08-18 | The Secretary Of State For Defence, Salisbury | Mutierte luziferasen |
| JPH08294397A (ja) | 1995-04-27 | 1996-11-12 | Nippon Oil & Fats Co Ltd | 免疫学的活性物質の測定方法 |
| US5998204A (en) | 1997-03-14 | 1999-12-07 | The Regents Of The University Of California | Fluorescent protein sensors for detection of analytes |
| GB9707486D0 (en) | 1997-04-11 | 1997-05-28 | Secr Defence | Enzyme assays |
| US6429286B1 (en) | 1997-04-16 | 2002-08-06 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Immunoregulatory molecules for costimulatory signal transduction |
| US6602677B1 (en) | 1997-09-19 | 2003-08-05 | Promega Corporation | Thermostable luciferases and methods of production |
| CA2301828A1 (fr) | 1997-09-19 | 1999-03-25 | Promega Corporation | Luciferases thermostables et leurs procedes de production |
| GB9823468D0 (en) | 1998-10-28 | 1998-12-23 | Secr Defence | Novel enzyme |
| JP3694181B2 (ja) | 1999-01-05 | 2005-09-14 | キッコーマン株式会社 | 変異型ルシフェラーゼ、変異型ルシフェラーゼ遺伝子、新規な組み換え体ｄｎａ及び変異型ルシフェラーゼの製造法 |
| ES2292479T3 (es) | 1999-10-26 | 2008-03-16 | The Secretary Of State For Defence | Luciferasa mutante. |
| GB9925161D0 (en) | 1999-10-26 | 1999-12-22 | Secr Defence | Novel enzyme |
| US20010046687A1 (en) | 2000-03-31 | 2001-11-29 | Dicesare Joseph L. | Method for the enhancement of luminescence intensity from a reaction between adenosine triphosphate (ATP) and a luciferase/luciferin reactant system |
| DE60142761D1 (de) | 2000-04-26 | 2010-09-23 | Chisso Corp | Oplophorus Luciferase |
| JP4613441B2 (ja) * | 2000-04-26 | 2011-01-19 | チッソ株式会社 | 新規ルシフェラーゼおよび発光蛋白質 |
| US7118878B1 (en) | 2000-06-09 | 2006-10-10 | Promega Corporation | Method for increasing luminescence assay sensitivity |
| US7879540B1 (en) | 2000-08-24 | 2011-02-01 | Promega Corporation | Synthetic nucleic acid molecule compositions and methods of preparation |
| US7268229B2 (en) | 2001-11-02 | 2007-09-11 | Promega Corporation | Compounds to co-localize luminophores with luminescent proteins |
| US7148030B2 (en) | 2002-02-01 | 2006-12-12 | Promega Corporation | Bioluminescent protease assay |
| CA2497560A1 (fr) | 2002-09-20 | 2004-04-01 | Promega Corporation | Procedes fondes sur la luminescence et sondes permettant de mesurer l'activite du cytochrome p450 |
| DE60203123T2 (de) | 2002-10-21 | 2005-07-21 | Axxam S.R.L. | Photoprotein mit verbesserter Biolumineszenz |
| WO2004059294A2 (fr) | 2002-12-23 | 2004-07-15 | Promega Corporation | Amelioration portant sur des analyses a base de luciferase |
| US7429472B2 (en) | 2003-01-31 | 2008-09-30 | Promega Corporation | Method of immobilizing a protein or molecule via a mutant dehalogenase that is bound to an immobilized dehalogenase substrate and linked directly or indirectly to the protein or molecule |
| EP2369006B1 (fr) | 2003-01-31 | 2014-03-12 | Promega Corporation | Fixation covalente de groupes fonctionnels à des protéines |
| US20040224377A1 (en) | 2003-02-12 | 2004-11-11 | Erika Hawkins | Compositions and methods to quench light from optical reactions |
| US20040178545A1 (en) | 2003-03-14 | 2004-09-16 | Cates Larry E. | System for optically analyzing a molten metal bath |
| EP2308978B8 (fr) | 2003-10-10 | 2015-04-08 | Promega Corporation | Biocapteur à la luciférase |
| EP1704157B1 (fr) | 2004-01-08 | 2009-09-16 | Universität Zürich | Complexes metalliques utilisant de la vitamine b12 comme ligand |
| US7416854B2 (en) | 2004-01-22 | 2008-08-26 | Promega Corporation | Luminogenic and nonluminogenic multiplex assay |
| US7553632B2 (en) | 2004-01-22 | 2009-06-30 | Promega Corporation | Luminogenic and nonluminogenic multiplex assay |
| EP2395358B1 (fr) | 2004-07-30 | 2017-03-29 | Promega Corporation | Fixation covalente de groupes fonctionnels à des protéines |
| US7425436B2 (en) | 2004-07-30 | 2008-09-16 | Promega Corporation | Covalent tethering of functional groups to proteins and substrates therefor |
| US20070087400A1 (en) | 2004-07-30 | 2007-04-19 | Aldis Darzins | Covalent tethering of functional groups to proteins and substrates therefor |
| US7728118B2 (en) | 2004-09-17 | 2010-06-01 | Promega Corporation | Synthetic nucleic acid molecule compositions and methods of preparation |
| JP4639904B2 (ja) | 2005-03-30 | 2011-02-23 | チッソ株式会社 | 蛍光活性を有するルシフェラーゼの活性増強方法 |
| JP3844082B2 (ja) * | 2005-04-08 | 2006-11-08 | キッコーマン株式会社 | 耐熱性ホタルルシフェラーゼ、耐熱性ホタルルシフェラーゼ遺伝子、新規な組み換え体ｄｎａ及び耐熱性ホタルルシフェラーゼの製造法 |
| EP1935986B1 (fr) | 2005-05-31 | 2014-04-16 | Promega Corporation | Composés luminogènes et fluorogènes et procédés pour la détection de molécules ou de conditions |
| EP2272973B1 (fr) | 2005-05-31 | 2015-05-27 | Promega Corporation | Composés luminogènes et fluorogènes et procédés pour la détection de molécules ou de conditions |
| US7495579B2 (en) | 2005-06-13 | 2009-02-24 | Sirota J Marcos | Traffic light status remote sensor system |
| AU2006281012A1 (en) | 2005-08-17 | 2007-02-22 | Yeda Research And Development Co. Ltd. | Methods and compositions for determining a level of biologically active serum paraoxonase |
| JP4999341B2 (ja) * | 2005-09-06 | 2012-08-15 | 株式会社バイオエネックス | 変異型ホタルルシフェラーゼ、遺伝子、組換えベクター、形質転換体、及び変異型ホタルルシフェラーゼの製造方法 |
| US9359635B2 (en) | 2006-04-03 | 2016-06-07 | Promega Corporation | Permuted and nonpermuted luciferase biosensors |
| JP2007306871A (ja) | 2006-05-19 | 2007-11-29 | Chisso Corp | 封入体可溶化方法及び精製方法 |
| US8420367B2 (en) | 2006-10-30 | 2013-04-16 | Promega Corporation | Polynucleotides encoding mutant hydrolase proteins with enhanced kinetics and functional expression |
| WO2008086035A2 (fr) | 2007-01-10 | 2008-07-17 | Promega Corporation | Rapporteur de fusion d'hydrolase mutante divisée et utilisations de celui-ci |
| WO2008118445A1 (fr) | 2007-03-26 | 2008-10-02 | Promega Corporation | Procédés pour réprimer des réactions optiques d'une lumière |
| WO2009061413A2 (fr) | 2007-11-05 | 2009-05-14 | Promega Corporation | Reporteur de fusion hybride et ses utilisations |
| EP2281046B1 (fr) | 2008-05-19 | 2012-01-25 | Promega Corporation | Biocapteurs de luciférase pour l'ampc |
| JP5753083B2 (ja) | 2008-07-22 | 2015-07-22 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | Ａｄｐ検出に基づく発光ホスホトランスフェラーゼまたはａｔｐヒドロラーゼのアッセイ法 |
| TWI375901B (en) | 2008-08-05 | 2012-11-01 | Elan Microelectronics Corp | Touch screen and method for positioning coordinate |
| JP5582505B2 (ja) * | 2009-02-09 | 2014-09-03 | Ｊｎｃ株式会社 | セレンテラジン類縁体及びその製造方法 |
| JPWO2010119721A1 (ja) * | 2009-04-17 | 2012-10-22 | 独立行政法人産業技術総合研究所 | 超高輝度で安定な人工生物発光酵素 |
| JP6038649B2 (ja) * | 2009-05-01 | 2016-12-07 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | 増大した光出力を有する合成オプロフォルスルシフェラーゼ |
| WO2011038219A1 (fr) | 2009-09-24 | 2011-03-31 | Promega Corporation | Protéases ayant une stabilité, une solubilité et une activité améliorées |
| JP5605727B2 (ja) * | 2010-04-06 | 2014-10-15 | Ｊｎｃ株式会社 | セレンテラジン類縁体及びセレンテラミド類縁体 |
| WO2011143339A1 (fr) | 2010-05-11 | 2011-11-17 | Promega Corporation | Biocapteurs de protéase mutante dotés de caractéristiques de détection améliorées |
| EP2611929B1 (fr) | 2010-09-01 | 2016-01-13 | Promega Corporation | Dosage de glutathion oxydé |
| US9284188B2 (en) | 2010-09-03 | 2016-03-15 | The Regents Of The University Of California | Cytosolic delivery of materials with endosome-disrupting colloids |
| PT2635583E (pt) * | 2010-11-02 | 2015-09-11 | Promega Corp | Derivados da coelenterazina e métodos de utilização da mesma |
| JP5889910B2 (ja) | 2010-11-02 | 2016-03-22 | プロメガ コーポレイションＰｒｏｍｅｇａ Ｃｏｒｐｏｒａｔｉｏｎ | 新規セレンテラジン基質及び使用法 |
| EP2751089B1 (fr) | 2011-09-02 | 2018-11-14 | Promega Corporation | Composés et procédés pour évaluer l'état redox de cellules métaboliquement actives et procédés de mesure de nad(p)/nad(p)h |
-
2011
- 2011-11-02 JP JP2013537799A patent/JP5889910B2/ja active Active
- 2011-11-02 EP EP19150069.3A patent/EP3498710A1/fr active Pending
- 2011-11-02 SG SG10201607774RA patent/SG10201607774RA/en unknown
- 2011-11-02 KR KR1020137014030A patent/KR101939553B1/ko active IP Right Grant
- 2011-11-02 SG SG10202103336SA patent/SG10202103336SA/en unknown
- 2011-11-02 DK DK11785534.6T patent/DK2635595T3/en active
- 2011-11-02 ES ES11785534T patent/ES2723773T3/es active Active
- 2011-11-02 EP EP11782732.9A patent/EP2635582B1/fr active Active
- 2011-11-02 SG SG10201608550SA patent/SG10201608550SA/en unknown
- 2011-11-02 CA CA2817102A patent/CA2817102C/fr active Active
- 2011-11-02 EP EP11785534.6A patent/EP2635595B1/fr active Active
- 2011-11-02 CA CA3081115A patent/CA3081115A1/fr active Pending
- 2011-11-02 AU AU2011323418A patent/AU2011323418B2/en active Active
- 2011-11-02 BR BR112013010855A patent/BR112013010855A2/pt not_active Application Discontinuation
- 2011-11-02 SG SG2013033675A patent/SG190104A1/en unknown
- 2011-11-02 CA CA2815227A patent/CA2815227C/fr active Active
- 2011-11-02 CN CN201180062485.1A patent/CN103370319B/zh active Active
- 2011-11-02 ES ES11782732T patent/ES2567410T3/es active Active
- 2011-11-02 WO PCT/US2011/059018 patent/WO2012061530A2/fr active Application Filing
- 2011-11-02 SG SG2013030366A patent/SG189496A1/en unknown
- 2011-11-02 PL PL11785534T patent/PL2635595T3/pl unknown
- 2011-11-02 CN CN201180063659.6A patent/CN103443121B/zh active Active
- 2011-11-02 EP EP19150036.2A patent/EP3498709A1/fr active Pending
- 2011-11-02 US US13/287,992 patent/US8809529B2/en active Active
- 2011-11-02 US US13/287,986 patent/US8669103B2/en active Active
- 2011-11-02 WO PCT/US2011/059017 patent/WO2012061529A1/fr active Application Filing
- 2011-11-02 PT PT11785534T patent/PT2635595T/pt unknown
- 2011-11-02 DK DK11782732.9T patent/DK2635582T3/da active
- 2011-11-02 CN CN201610172245.1A patent/CN106148362B/zh active Active
- 2011-11-02 JP JP2013537800A patent/JP6155424B2/ja active Active
- 2011-11-02 KR KR1020137014102A patent/KR101538624B1/ko active IP Right Grant
- 2011-11-02 BR BR112013010487-2A patent/BR112013010487B1/pt active IP Right Grant
- 2011-11-02 PL PL11782732T patent/PL2635582T3/pl unknown
-
2013
- 2013-04-21 IL IL225867A patent/IL225867B/en active IP Right Grant
- 2013-05-02 IL IL226114A patent/IL226114B/en active IP Right Grant
-
2014
- 2014-01-21 US US14/160,282 patent/US9951373B2/en active Active
- 2014-01-21 US US14/160,278 patent/US9840730B2/en active Active
- 2014-08-18 US US14/461,610 patent/US9139836B2/en active Active
-
2015
- 2015-09-21 US US14/859,715 patent/US9938564B2/en active Active
-
2016
- 2016-02-12 JP JP2016024952A patent/JP6374420B2/ja active Active
- 2016-02-17 JP JP2016028303A patent/JP6574721B2/ja active Active
- 2016-08-12 AU AU2016213854A patent/AU2016213854B2/en active Active
-
2017
- 2017-04-21 JP JP2017084390A patent/JP6539689B2/ja active Active
-
2018
- 2018-03-06 JP JP2018040100A patent/JP6752839B2/ja active Active
- 2018-04-09 US US15/948,070 patent/US10774364B2/en active Active
- 2018-04-18 IL IL258790A patent/IL258790B/en active IP Right Grant
-
2020
- 2020-04-28 IL IL274316A patent/IL274316B/en unknown
- 2020-09-03 US US17/011,597 patent/US11661623B2/en active Active
-
2021
- 2021-05-27 US US17/332,459 patent/US20220348983A1/en active Pending
- 2021-11-14 IL IL288070A patent/IL288070B2/en unknown
-
2023
- 2023-09-21 US US18/471,901 patent/US20240158831A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288070B (en) | Luciferases derived from Eulophorus, new coelantrazine materials and methods of use | |
| HK1243417A1 (zh) | 吡啶酮和氮雜吡啶酮化合物及使用方法 | |
| IL248530A0 (en) | Biomarkers and treatment methods | |
| IL247595A0 (en) | New modulators and methods of use | |
| IL222227A0 (en) | Pyrazol - 4 - heterocyclyl-carboxamide compounds and methods of use | |
| EP2536756A4 (fr) | Compositions relatives a l'albumine serique humaine et leurs methodes d'utilisation | |
| IL225869A (en) | Colentrazine derivatives and methods for their use | |
| EP2584897A4 (fr) | Compositions contenant du resvératrol et procédés d'utilisation | |
| EP2616442B8 (fr) | Inhibiteurs de pi3k-delta et leurs procédés d'utilisation et fabrication | |
| ZA201300612B (en) | Novel bacteria and methods of use thereof | |
| EP2529079A4 (fr) | Agent de soutènement auto-durci à haute résistance et procédés de fabrication associés | |
| EP2539005A4 (fr) | Pièce buccale et procédés d'utilisation de celui-ci | |
| SG10201601792UA (en) | Novel modulators and methods of use | |
| EP2536283B8 (fr) | Dérivés de phényl-hétéroaryle et procédés d'utilisation de ceux-ci | |
| EP2596112A4 (fr) | Compositions d'acétylcystéine et méthodes d'utilisation correspondantes | |
| EP2464227A4 (fr) | Composés et leurs procédés d utilisation | |
| EP2536709A4 (fr) | Inhibiteurs de la prolylhydroxylase et procédés d'utilisation | |
| EP2611791A4 (fr) | Oligooxopipérazines et procédés pour leur préparation et leur utilisation | |
| GB2479023C (en) | Construction panel and method of use thereof | |
| EP2542056A4 (fr) | Composition à effet désherbant et procédé d'utilisation associé | |
| HK1174620A1 (zh) | 吲唑基取代的二氫異噁唑並吡啶及其使用方法 | |
| ZA201301175B (en) | Biomarkers and methods of treatment | |
| AU2010900187A0 (en) | Methods of Treatment and Immunotherapy |